Yi Zhang | |
|---|---|
&sq=Google&lang=en&file=File:HHMI_Yi_Zhang.jpg) | |
| Born | Zhang Yi Chongqing, China |
| Education | B.Sc. and master's degree in biophysics from China Agricultural University Ph.D. in molecular biophysics from Florida State University |
| Known for | Epigenetics Embryogenesis Somatic cell nuclear transfer Stem cell |
| Scientific career | |
| Institutions | Harvard Medical School Boston Children's Hospital Howard Hughes Medical Institute |
| Academic advisors | Danny Reinberg |
| Website | www |
Yi Zhang (Chinese: 张毅; pinyin: Zhāng Yì) is a Chinese-American biochemist who specializes in the fields of epigenetics, chromatin, and developmental reprogramming. He is a Fred Rosen Professor of Pediatrics and professor of genetics at Harvard Medical School,[1] a senior investigator of Program in Cellular and Molecular Medicine at Boston Children's Hospital,[2] and an investigator of the Howard Hughes Medical Institute.[3] He is also an associate member of the Harvard Stem Cell Institute,[4] as well as the Broad Institute of MIT and Harvard.[5] He is best known for his discovery of several classes of epigenetic enzymes and the identification of epigenetic barriers of SCNT cloning.
- ^ "Yi Zhang". Harvard Medical School. Retrieved 2018-12-10.
- ^ "Yi Zhang, PhD". Boston Children's Hospital. Retrieved 2018-12-10.
- ^ "Yi Zhang". HHMI. Retrieved 2018-12-10.
- ^ "Yi Zhang, PhD". hsci.harvard.edu. Retrieved 2018-12-12.
- ^ "Our faculty: Associate and affiliate members". Broad Institute. 2008-05-08. Retrieved 2018-12-12.